Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

ClinicalTrials.gov ID: NCT03996447

Public ClinicalTrials.gov record NCT03996447. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 3:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03996447
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Guerbet
Industry
Enrollment
260 participants

Conditions and interventions

Interventions

  • Gadobutrol 1Mmol/mL Solution for Injection Vial Drug
  • gadopiclenol Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2, 2019
Primary completion
Sep 10, 2020
Completion
Sep 10, 2020
Last update posted
Sep 21, 2025

2019 – 2020

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
ASCLEPES Research Centers Panorama City California 91402
University of Connecticut Health Center Farmington Connecticut 06030
Northwestern Memorial Hospital Chicago Illinois 60611
Northwest Neurology, Ltd. Rolling Meadows Illinois 600008
University of Missouri Hospital and Clinic Columbia Missouri 65212
University Of Pennsylvania Philadelphia Pennsylvania 19104
South Carolina Clinical & Translational Research (SCTR) Institute Charleston South Carolina 29425
University Of Washington - Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03996447, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03996447 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →